The robust anti-tumor phenotype in Cav-2 KO mice is evidenced by the results obtained using two independent syngeneic models of tumor growth in immunocompetent mice involving subcutaneous implantation with LLC and CMT 167 lung carcinoma cell lines. This evidence concerns the gene CAV2 and neoplasm.